Jeff Yass’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Jeff Yass's PVLA Position: Q3 2026 in Review
Jeff Yass reduced its Palvella Therapeutics (PVLA) stake by 83% in Q3 2026, selling an estimated $2.14M and leaving 2,966 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #10251.
Jeff Yass first reported a position in PVLA in Q2 2015 and has held it in 26 quarters since. The position peaked at $3.2M in Q1 2025. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Jeff Yass held 2,966 shares of Palvella Therapeutics worth $409K as of Q3 2026.
- Jeff Yass sold 14,431 Palvella Therapeutics shares in Q3 2026, an estimated $2.14M.
- Palvella Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10251 holding.
- Jeff Yass first reported a position in Palvella Therapeutics in Q2 2015 and has held it in 26 quarters since.
- Jeff Yass's Palvella Therapeutics position peaked at $3.2M in Q1 2025.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.